In vivo biocompatibility and degradability of a novel injectable-chitosan-based implant

Fwu Long Mi, Yu Chiun Tan, Hsiang F. Liang, Hsing W. Sung

研究成果: 雜誌貢獻文章同行評審

463 引文 斯高帕斯(Scopus)

摘要

A novel injectable-chitosan-based delivery system with low cytotoxicity was fabricated in the study. The chitosan microspheres with small particle size, low crystallinity and good sphericity were prepared by a spray-drying method followed by treating with a crosslinker. In the study, a naturally occurring crosslinking reagent (genipin), which has been used in herbal medicine and in the production of food dyes, was used to crosslink the chitosan microspheres. The glutaraldehyde-crosslinked counterparts were used as a control. Histological study of the genipin-crosslinked chitosan microspheres injected intramuscularly into the skeletal muscle of a rat model showed a less inflammatory reaction than its glutaraldehyde-crosslinked counterparts. The results of the scanning electron microscopic examination indicated that the glutaraldehyde-crosslinked chitosan microspheres retrieved at 12-week postoperatively were already degraded into a loose and porous structure. However, the degradation of the genipin-crosslinked chitosan microspheres was not significant after 20 weeks of implantation. The results of the study demonstrated that the genipin-crosslinked chitosan microspheres have a superior biocompatibility and a slower degradation rate than the glutaraldehyde-crosslinked chitosan microspheres. Accordingly, the genipin-crosslinked chitosan microspheres may be a suitable polymeric carrier for long-acting injectable drug delivery.

原文英語
頁(從 - 到)181-191
頁數11
期刊Biomaterials
23
發行號1
DOIs
出版狀態已發佈 - 一月 1 2002
對外發佈Yes

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Biomedical Engineering

指紋 深入研究「In vivo biocompatibility and degradability of a novel injectable-chitosan-based implant」主題。共同形成了獨特的指紋。

引用此